Navigation Links
Industry Veteran, John Maroney, to Join ForSight VISION5 as President and CEO

MENLO PARK, Calif., June 17, 2013 /PRNewswire/ -- ForSight VISION5 is pleased to announce that John F. Maroney will join the company as President, CEO and Director of VISION5, and that the company has recently closed its Series B-1 round of funding. ForSight VISION5 is the fifth company created by Menlo Park ophthalmic incubator ForSight Labs. VISION5 is a clinical development stage company focused on unmet needs in ophthalmic diseases, initially ocular hypertension and glaucoma.

Since 2003, Mr. Maroney has served as a Managing Member of Delphi Ventures, a healthcare focused venture capital firm with more than $1.1B in capital raised across eight funds.  Mr. Maroney will continue to serve as a Venture Partner for Delphi Ventures with responsibility for various portfolio companies. Prior to joining Delphi, Mr. Maroney was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents.  EndoTex was acquired by Boston Scientific Corp. in 2007. From 1988 to 1997, Mr. Maroney held a variety of senior management positions at Cardiovascular Imaging Systems (CVIS) and Boston Scientific including President of EP Technologies, Inc., and Vice President and General Manager for Cardiovascular Imaging Systems. While at CVIS, Mr. Maroney was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation.  Prior to CVIS, Mr. Maroney held increasingly responsible management roles at Abbott Laboratories via their acquisition of Oximetrix, Inc.  Mr. Maroney also currently serves on the Advisory Boards for the College of Engineering and the Department of BioMedical Engineering at UC Davis.

Mr. Maroney said, "I am thrilled to join and lead the exciting team at ForSight VISION5 brought together by Angela Macfarlane around the technology pioneered by Dr. Eugene de Juan, Jr. MD.  The investors are truly a world class group and I feel privileged to work with each of them."

Ms. Macfarlane said, "John's leadership, experience and deep understanding of how to build a powerful organization and drive a game-changing technology are a perfect fit for ForSight VISION5."  Dr. de Juan added, "It is very satisfying to see an experienced team come together around a compelling technology addressing key clinical needs while focused on improved, cost effective patient outcomes."

ForSight VISION5 has also completed its Series B-1 financing which raised $9.3m and was led by Technology Partners of Palo Alto, California and joined by Delphi Ventures.  Returning investors Morgenthaler Ventures and Versant Ventures also broadly supported the financing.  Jim Glasheen, PhD, of Technology Partners joins the ForSight VISION5 Board of Directors.  Dr. Glasheen commented "We are extremely excited about the VISION5 investment opportunity. The Company is targeting a compelling need for millions of patients in one of the key ophthalmic markets with the potential for impacting broader markets as the technology matures."

About ForSight VISION5 and ForSight Labs, LLC
ForSight VISION5, Inc., was founded in January of 2011 as the fifth company to spin out of the ophthalmic incubator ForSight Labs, LLC ( ForSight VISION5 is a clinical development stage company focused on unmet needs in ophthalmic diseases, initially ocular hypertension and glaucoma.  ForSight Labs, LLC, was established in 2005 by renowned ophthalmologist and retinal surgeon Eugene de Juan, Jr., MD in collaboration with The Foundry ( to start companies focused on impactful solutions to improve the sight, care, and quality of life of visually impaired patients.

About Morgenthaler Ventures
Morgenthaler Ventures is a premier venture capital firm with over $3 billion of committed capital. Morgenthaler has invested in more than 300 companies in the life science and information technology sectors, and has partnered with some of the world's most visionary entrepreneurs. Representative life science companies include: Ardian, OncoMed, Transcend, Nexis Vision, Promedior, Elcelyx, Holaira, Kona Medical, Moximed, Ra Pharmaceuticals, SetPoint Medical, Scioderm, Second Genome, and Silicon Valley-based incubators The Foundry and ForSight Labs.

About Versant Ventures
Versant Ventures is a leading venture capital firm that specializes in investment in innovative, groundbreaking bio-pharmaceuticals, medical devices, and other life science opportunities. Founded in 1999, the firm consists of an experienced team committed to helping entrepreneurs build successful companies that impact healthcare and improve quality of life.

About Technology Partners
Founded more than 25 years ago and based in Palo Alto, California, Technology Partners is a venture capital firm with an investment focus in the life science and cleantech industries. The firm manages approximately $700 million in investment capital. Technology Partners' strategy is to team with visionary entrepreneurs to build successful companies, serving principally as a lead investor and business advisor.

About Delphi Ventures
Delphi Ventures is a venture capital firm that has focused on investing in medical devices and biotechnology for over two decades. With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 100 of its portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation. Delphi Ventures is based in Menlo Park, California.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
3. Industry Veteran Brings Sales Expertise to AlloSources Growing Distribution Network
4. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
5. Industry Leading Pharmaceutical News Website Refocused and Relaunched
6. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
9. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
10. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report
11. UBM Canon, the Global MedTech Authority, Announces Strategic Alliance with ITG Market Research, a Preeminent Industry Research Organization
Post Your Comments:
(Date:11/24/2015)... 2015  DILON Diagnostics and GE Healthcare are pleased ... DILON to distribute GE,s Discovery NM750b Molecular Breast Imaging ... this distribution agreement will provide Dilon,s experienced distribution network ... and is considered an initial step in an ongoing ... clinicians and their patients. --> ...
(Date:11/24/2015)... November 24, 2015 Sectra (STO: ... has entered into a multi-year agreement to deploy ... investment will provide the Breast Center a future-proof platform ... (STO: SECT B) announces that Breast Center of ... deploy Breast Imaging PACS in its two freestanding imaging ...
(Date:11/24/2015)... FRAMINGHAM, Mass. , Nov. 24, 2015   ... leading innovator of less-invasive, miniaturized circulatory support technologies that ... announced that President and Chief Executive Officer Doug ... Jaffray 27 th Annual Healthcare Conference on December ... being held December 1-2 in New York ...
Breaking Medicine Technology:
(Date:11/25/2015)... WASHINGTON, D.C. (PRWEB) , ... November 25, 2015 , ... ... driving fatalities on our nation’s roadways has dropped below 10,000 for the first time ... to 10,076 in 2013. , According to data released by the National Highway Traffic ...
(Date:11/25/2015)... ... November 25, 2015 , ... An ... is resulting in a way for homeless people to have a more dignified ... a new initiative whereby they are repurposing plastic bags into sleeping mats for ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... offering lower prices in an early celebration of the early holiday shopping season. ... of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a ... Dr. Angela Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in ... and fillings, the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the ...
(Date:11/24/2015)... ... 24, 2015 , ... DMG Productions announced that they will feature Aphria, Inc., ... via Discovery Channel. Dates and show times TBA. , Aphria, Inc., is a publicly ... of producing and supplying medical marijuana pursuant to the Marijuana for Medical Purposes Regulations ...
Breaking Medicine News(10 mins):